Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
Silexion Therapeutics stock last closed at $3.30, down 4.07% from the previous day, and has decreased 91.69% in one year. It has underperformed other stocks in the Biotechnology industry by 0.68 percentage points. Silexion Therapeutics stock is currently +1.54% from its 52-week low of $3.25, and -94.8% from its 52-week high of $63.45.
At the moment, there are 731,642 shares of SLXN outstanding. The market capitalization of SLXN is $2.41M. In the last 24 hours, 52,000 SLXN shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy SLXN shares.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal information so you can buy SLXN stock today.
Now that you've opened your account on a investment app, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of depositing money into your brokerage account.
After you have selected the best place to buy Silexion Therapeutics stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk and opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SLXN's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge SLXN's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on SLXN's stock here.
You can dive deeper into what analysts are forecasting on the Silexion Therapeutics stock forecast page.
Over the last 12 months, executives and large shareholders at SLXN have not bought or sold any shares.
Research more about who owns SLXN stock here.
No, Silexion Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary order types:
Click the Open button and eToro will execute the order.
If you want more help with buying stocks on eToro, click the helpful video below:
Now that you own some SLXN shares, you'll want to keep up with your shares.
Start a watchlist to track your SLXN stock.
To summarize, here are the 6 steps you need to take to buy Silexion Therapeutics stock right now:
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Silexion Therapeutics, create a watchlist today.